# China NMPA Drug Inspection - Xiangbei Wellman Pharmaceutical Co., Ltd. - Amoxicillin Clavulanate Potassium Tablets

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/xiangbei-wellman-pharmaceutical-co-ltd/f0b41000-5c7b-4dab-86e9-23e4536507bf/
Source feed: China

> China NMPA drug inspection for Xiangbei Wellman Pharmaceutical Co., Ltd. published June 17, 2021. Drug: Amoxicillin Clavulanate Potassium Tablets. 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Guangdong Provincial Drug Administration's Announcement Regarding Drug Sampling and Inspection Information (Issue 5, 2021)
- Company Name: Xiangbei Wellman Pharmaceutical Co., Ltd.
- Publication Date: 2021-06-17
- Drug Name: Amoxicillin Clavulanate Potassium Tablets
- Inspection Finding: Compliant with drug standards

Company: https://www.globalkeysolutions.net/companies/xiangbei-wellman-pharmaceutical-co-ltd/1adf8beb-b9df-4cd3-902c-cba4e855ec39/